📰 Pediatric Study Plan News
Page 2 - Pediatric Study Plan News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Pediatric Study Plan. Real-time updates on events, politics, business and more.
December 20, 2022
EQS-News: ABIVAX / Key word(s): Study Abivax receives FDA agreement on pediatric development plan with obefazimod in IBD 20.12...
December 3, 2022
This white paper examines specific considerations and planning for pediatric oncology trials, and the changing landscape in pediatric oncology...
August 11, 2022
11.08.2022 - $5 Million of Non-Dilutive FinancingVeteran Biotech Executive Appointed to Board KANSAS CITY, Kan., Aug. 11, 2022 (GLOBE NEWSWIRE) - Cingulate Inc. (NASDAQ: CING), a clinical-stage biopharmaceutical company utilizing its proprietary Precision ...
May 12, 2022
Announcement of First Dosage for Anxiety Candidate CTx-2103 to Extend the Application of the Precision Timed Release™ Platform KANSAS CITY, Kan., May 12, 2022 -- Cingulate Inc. , a... | May 12, 2022
September 16, 2021
This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No 596/2014. Cambridge, UK and...
May 18, 2021
Search jobs 18-May-2021 EQS Group-News: RELIEF THERAPEUTICS Holdings AG / Key word(s): Miscellaneous 18.05.2021 / 07:00 Geneva, Switzerland, May 18, 2021 - RELIEF THERAPEUTICS Holding AG (SIX: RLF, OTCQB: RLFTF)(" Relief"), a biopharmaceutical company with its lead compound RLF-100 TM (aviptadil) in advanced clinical development to treat severe COVID-19 patients, today provided an update on the development of ACER-001, a proprietary powder formulation of sodium phenylbuty...
May 18, 2021
Relief"), a biopharmaceutical company with its lead compound RLF-100 TM (aviptadil) in advanced clinical development to treat severe COVID-19 patients, today provided an update on the development of ACER-001, a proprietary powder formulation of sodium phenylbutyrate (NaPB) designed to be both taste-masked and immediate release, in the lead indication, urea cycle disorders (UCDs). UCDs are a group of rare genetic metabolic disorders which can lead to an excess accumulation of ammonia in the bloo...